117 related articles for article (PubMed ID: 38566355)
1. PDP1 promotes the progression of breast cancer through STAT3 pathway.
Wang Y; Dang H; Qiao H; Tian Y; Guan Q
Cell Biochem Funct; 2024 Apr; 42(3):e3994. PubMed ID: 38566355
[TBL] [Abstract][Full Text] [Related]
2. P16 promotes the growth and mobility potential of breast cancer both in vitro and in vivo: the key role of the activation of IL-6/JAK2/STAT3 signaling.
Wang L; Zhan X; Shen X; Li M; Yang J; Yu W; Chen H; Jin B; Mao Z
Mol Cell Biochem; 2018 Sep; 446(1-2):137-148. PubMed ID: 29388151
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA VCAN-AS1 promotes the malignant behaviors of breast cancer by regulating the miR-106a-5p-mediated STAT3/HIF-1α pathway.
Du P; Luo K; Li G; Zhu J; Xiao Q; Li Y; Zhang X
Bioengineered; 2021 Dec; 12(1):5028-5044. PubMed ID: 34365889
[TBL] [Abstract][Full Text] [Related]
4. Rho GTPase Activating Protein 24 (ARHGAP24) Regulates the Anti-Cancer Activity of Sorafenib Against Breast Cancer MDA-MB-231 Cells via the Signal Transducer and Activator of Transcription 3 (STAT3) Signaling Pathway.
Dai X; Geng F; Dai J; Li M; Liu M
Med Sci Monit; 2018 Nov; 24():8669-8677. PubMed ID: 30499465
[TBL] [Abstract][Full Text] [Related]
5. Homeodomain-containing gene 10 contributed to breast cancer malignant behaviors by activating Interleukin-6/Janus kinase 2/Signal transducer and activator of transcription 3 pathway.
Shen J; Wang M; Li F; Yan H; Zhou J
Bioengineered; 2022 Jan; 13(1):1335-1345. PubMed ID: 34983296
[TBL] [Abstract][Full Text] [Related]
6. Fat mass and obesity-associated protein (FTO) mediates signal transducer and activator of transcription 3 (STAT3)-drived resistance of breast cancer to doxorubicin.
Wang Y; Cheng Z; Xu J; Lai M; Liu L; Zuo M; Dang L
Bioengineered; 2021 Dec; 12(1):1874-1889. PubMed ID: 34076564
[TBL] [Abstract][Full Text] [Related]
7.
Li Y; Wei J; Sun Y; Zhou W; Ma X; Guo J; Zhang H; Jin T
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958803
[TBL] [Abstract][Full Text] [Related]
8. Novel sorafenib analogues induce apoptosis through SHP-1 dependent STAT3 inactivation in human breast cancer cells.
Liu CY; Tseng LM; Su JC; Chang KC; Chu PY; Tai WT; Shiau CW; Chen KF
Breast Cancer Res; 2013; 15(4):R63. PubMed ID: 23938089
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of pyruvate dehydrogenase phosphatase 1 promotes the progression of pancreatic adenocarcinoma by regulating energy-related AMPK/mTOR signaling.
Li Y; Shen J; Cheng CS; Gao H; Zhao J; Chen L
Cell Biosci; 2020; 10():95. PubMed ID: 32782783
[TBL] [Abstract][Full Text] [Related]
10. Stress-induced phosphoprotein 1 facilitates breast cancer cell progression and indicates poor prognosis for breast cancer patients.
Lin L; Wen J; Lin B; Xia E; Zheng C; Ye L; Wang Y; Wang O; Chen Y
Hum Cell; 2021 May; 34(3):901-917. PubMed ID: 33665786
[TBL] [Abstract][Full Text] [Related]
11. An azaspirane derivative suppresses growth and induces apoptosis of ER-positive and ER-negative breast cancer cells through the modulation of JAK2/STAT3 signaling pathway.
Sulaiman NB; Mohan CD; Basappa S; Pandey V; Rangappa S; Bharathkumar H; Kumar AP; Lobie PE; Rangappa KS
Int J Oncol; 2016 Sep; 49(3):1221-9. PubMed ID: 27500741
[TBL] [Abstract][Full Text] [Related]
12. KIF2C promotes clear cell renal cell carcinoma progression via activating JAK2/STAT3 signaling pathway.
Deng H; Gong X; Ji G; Li C; Cheng S
Mol Cell Probes; 2023 Dec; 72():101938. PubMed ID: 37863123
[TBL] [Abstract][Full Text] [Related]
13. Hsa_circ_001569 is an unfavorable prognostic factor and promotes cell proliferation and metastasis by modulating PI3K-AKT pathway in breast cancer.
Xu JH; Wang Y; Xu D
Cancer Biomark; 2019; 25(2):193-201. PubMed ID: 31104012
[TBL] [Abstract][Full Text] [Related]
14. LncRNA CASC9 activated by STAT3 promotes the invasion of breast cancer and the formation of lymphatic vessels by enhancing H3K27ac-activated SOX4.
Fan SJ; Cui Y; Li YH; Xu JC; Shen YY; Huang H; Hu ZC
Kaohsiung J Med Sci; 2022 Sep; 38(9):848-857. PubMed ID: 35860965
[TBL] [Abstract][Full Text] [Related]
15. STAT3-induced HLA-F-AS1 promotes cell proliferation and stemness characteristics in triple negative breast cancer cells by upregulating TRABD.
Wu D; Jia H; Zhang Z; Li S
Bioorg Chem; 2021 Apr; 109():104722. PubMed ID: 33618253
[TBL] [Abstract][Full Text] [Related]
16. Obatoclax analog SC-2001 inhibits STAT3 phosphorylation through enhancing SHP-1 expression and induces apoptosis in human breast cancer cells.
Liu CY; Su JC; Ni MH; Tseng LM; Chu PY; Wang DS; Tai WT; Kao YP; Hung MH; Shiau CW; Chen KF
Breast Cancer Res Treat; 2014 Jul; 146(1):71-84. PubMed ID: 24903225
[TBL] [Abstract][Full Text] [Related]
17. I157172, a novel inhibitor of cystathionine γ-lyase, inhibits growth and migration of breast cancer cells via SIRT1-mediated deacetylation of STAT3.
Wang L; Shi H; Zhang X; Zhang X; Liu Y; Kang W; Shi X; Wang T
Oncol Rep; 2019 Jan; 41(1):427-436. PubMed ID: 30365149
[TBL] [Abstract][Full Text] [Related]
18. MYCL promotes the progression of triple‑negative breast cancer by activating the JAK/STAT3 pathway.
Jiang H; Li X; Wang W; Hu Y; Ren D
Oncol Rep; 2022 Nov; 48(5):. PubMed ID: 36177900
[TBL] [Abstract][Full Text] [Related]
19. ZIC2 is downregulated and represses tumor growth via the regulation of STAT3 in breast cancer.
Liu ZH; Chen ML; Zhang Q; Zhang Y; An X; Luo YL; Liu XM; Liu SX; Liu Q; Yang T; Liu YM; Liu BL; Zhou AJ; Li MZ; Liu YJ; Liu ZX; Zhong Q
Int J Cancer; 2020 Jul; 147(2):505-518. PubMed ID: 32064600
[TBL] [Abstract][Full Text] [Related]
20. CD151 promotes breast cancer metastasis by activating TGF-β1/Smad signaling pathway.
Zhao SJ; Zhao HD; Li J; Zhang H; Gao DT; Wang Q
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7314-7322. PubMed ID: 30468476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
